Back to User profile » Dr Yanyang Liu

Papers published by Dr Yanyang Liu:


Anticancer Effects of ACT001 via NF-κB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1

Liu Y, Wang L, Liu J, Xie X, Hu H, Luo F

Cancer Management and Research 2020, 12:5131-5139

Published Date: 26 June 2020

Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway

Hu H, Liu Y, Tan S, Xie XX, He J, Luo F, Wang L

Cancer Management and Research 2020, 12:3579-3587

Published Date: 19 May 2020

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

Wang Y, Tu L, Du C, Xie X, Liu Y, Wang J, Li Z, Jiang M, Cao D, Yan X, Luo F

OncoTargets and Therapy 2018, 11:5559-5567

Published Date: 6 September 2018

The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer

Liu YY, Tu L, Wang L, Long J, Wang J, Wang Y, Luo F, Cao D

OncoTargets and Therapy 2016, 9:6581-6595

Published Date: 25 October 2016